Literature DB >> 7962174

Colocalization of the p185HER2 oncoprotein and integrin alpha 6 beta 4 in Calu-3 lung carcinoma cells.

M Campiglio1, E Tagliabue, U Srinivas, R Pellegrini, S Martignone, S Ménard, M I Colnaghi, L Lombardi, P C Marchisio.   

Abstract

Anti-p185HER2 monoclonal antibodies often show intense reactivity with the basement membrane of tumor cells that overexpress the HER2/neu gene product (p185HER2). To evaluate a possible interaction between p185HER2 and adhesion molecules or their receptors, the polarity of p185HER2 was tested in lung carcinoma cell line Calu-3, which overexpresses this protein, in cultures grown as confluent monolayers or as aggregates. MAb immunostaining patterns indicated that p185HER2 is concentrated on the baso-lateral membrane of cells and that it colocalizes with the integrin alpha 6 beta 4 at the cell-cell junctions where laminin is also found. The same membrane region showed intense reactivity with antiphosphotyrosine antibodies. Furthermore, integrin clustering induced by the specific antibody was accompanied by the clustering of p185HER2, as indicated by immunoelectron microscopy, and by a subsequent increase in p185HER2 tyrosine phosphorylation. Treatment with exogenous laminin also resulted in increased basal levels of p185HER2 phosphorylation. These data suggest a physical interaction between the integrin and the oncoprotein that might be functionally relevant in directly controlling the tyrosine phosphorylation of the catalytic domain of p185HER2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962174     DOI: 10.1002/jcb.240550402

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

Review 1.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

Review 2.  Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.

Authors:  P Nagy; A Jenei; S Damjanovich; T M Jovin; J Szölôsi
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 3.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

4.  Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.

Authors:  E Tagliabue; E Ardini; R Pellegrini; M Campiglio; R Bufalino; M Jeschke; B Groner; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

Review 5.  ErbB/integrin signaling interactions in regulation of myocardial cell-cell and cell-matrix interactions.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Biochim Biophys Acta       Date:  2012-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.